✦ LIBER ✦

Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma

✍ Scribed by Anthony T. C. Chan; Thomas W. T. Leung; Wing H. Kwan; Tony S. K. Mok; Winnie Yeo; Maria Lai; Philip J. Johnson

Publisher: Springer
Year: 1998
Tongue: English
Weight: 246 KB
Volume: 42
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050812

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II clinical study of gemcitabine i

Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy

✍ Li Zhang; Yang Zhang; Pei-Yu Huang; Fei Xu; Pei-Jian Peng; Zhong-Zhen Guan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 302 KB

Phase II study of gemcitabine and cispla

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

✍ Philip A. Philip; Mark M. Zalupski; V. K. Vaitkevicius; Patricia Arlauskas; Ruth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Phase II study of gemcitabine in patient

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Tai-Shen Yang; Yung-Chang Lin; Jen-Shi Chen; Hung-Ming Wang; Chen-Hsu Wang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 3 views

Phase II study of spirogermanium in pati

Phase II study of spirogermanium in patients with advanced colorectal carcinoma

✍ Jaffer A. Ajani; Jack S. Faintuch; Roxann K. McClure; Bernard Levin; Bruce M. Bo 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 193 KB

Twenty one evaluable patients with advanced colorectal carcinoma were treated with continuous infusion of spirogermanium at a median daily dose of 150 mg/rn 2 (range 120-210) for five consecutive days every 14 days. Treatments were accomplished by using outpatient infusion devices. Fifteen patients

Phase II study of pyrazoloacridine in pa

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma

✍ Mark M. Zalupski; Philip A. Philip; Patricia LoRusso; Anthony F. Shields 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 101 KB

A Phase II study of irinotecan in patien

A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma

✍ Eileen M. O'Reilly; Keith E. Stuart; Pedro M. Sanz-Altamira; Gary K. Schwartz; C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views